The MRI contrast agent gadoteridol enhances distribution of rAAV1 in the rat hippocampus

Gene Therapy

Volumn 20, Issue 12, 2013, Pages 1172-1177

  Hullinger, R ^a,b   Ugalde, J ^a   Puron Sierra L ^c   Osting, S ^a   Burger, C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c INSTITUTO DE NEUROBIOLOGÍA   (Mexico)

Author keywords

AAV; gadoteridol; hippocampus; spatial memory

Indexed keywords

GADOTERIDOL; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEIN; RINGER LACTATE SOLUTION; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN REGION; CONTROLLED STUDY; DENSITOMETRY; HEMISPHERE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RECOMBINANT ADENO ASSOCIATED VIRUS SEROTYPE 1; RECOMBINANT ADENO ASSOCIATED VIRUS SEROTYPE 5; SPATIAL MEMORY; TRANSGENE; TROPISM; VIRUS PARTICLE;

ADENO-ASSOCIATED VIRUS; ANIMALIA; RATTUS;

ANIMALS; DEPENDOVIRUS; GADOLINIUM; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HETEROCYCLIC COMPOUNDS; HIPPOCAMPUS; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC; VIRAL TROPISM;

EID: 84890120135     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2013.47     Document Type: Article

References (27)

1. Bartel MA, Weinstein JR, Schaffer DV. Directed evolution of novel adeno-associated viruses for therapeutic gene delivery. Gene Therapy 2012; 19: 694-700.
2. Mandel R, Burger C. Clinical trials in neurological disorders using AAV vectors: Promises and challenges. Curr Op Mol Therapeutics 2004; 6: 482-490.
3. McCown TJ, Xiao X, Li J, Breese GR, Samulski RJ. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99-107.
4. Sanlioglu S, Monick MM, Luleci G, Hunninghake GW, Engelhardt JF. Rate limiting steps of AAV transduction and implications for human gene therapy. Curr Gene Ther 2001; 1: 137-147.
5. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites Jr. TJ et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 2002; 28: 158-167.
6. Gao G, Vandenberghe LH, Wilson JM. New recombinant serotypes of AAV vectors. Curr Gene Ther 2005; 5: 285-297.
7. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 2008; 27: 59-65.
8. Ghodsi A, Stein C, Derksen T, Martins I, Anderson RD, Davidson BL. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer. Exp Neurol 1999; 160: 109-116.
9. Burger C, Nguyen FN, Deng J, Mandel RJ. Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion. Mol Ther 2005; 11: 327-331.
10. Carty N, Lee D, Dickey C, Ceballos-Diaz C, Jansen-West K, Golde TE et al. Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain. J Neurosci Methods 2010; 194: 144-153.
11. Su X, Kells AP, Salegio EA, Richardson RM, Hadaczek P, Beyer J et al. Real-time MR imaging with gadoteridol predicts distribution of transgenes after convectionenhanced delivery of AAV2 vectors. Mol Ther 2010; 18: 1490-1495.
12. Fiandaca MS, Varenika V, Eberling J, McKnight T, Bringas J, Pivirotto P et al. Realtime MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 2009; 47(Suppl 2): T27-T35.
13. Abujudeh HH, Kaewlai R, Kagan A, Chibnik LB, Nazarian RM, High WA et al. Nephrogenic systemic fibrosis after gadopentetate dimeglumine exposure: Case series of 36 patients. Radiology 2009; 253: 81-89.
14. Ding D, Kanaly CW, Cummings TJ, Herndon 2nd JE, Raghavan R, Sampson JH. Long-term safety of combined intracerebral delivery of free gadolinium and targeted chemotherapeutic agent PRX321. Neurol Res 2010; 32: 810-815.
15. Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302-317.
16. Gerstein H, O'Riordan K, Osting S, Schwarz M, Burger C. Rescue of synaptic plasticity and spatial learning deficits in the hippocampus of Homer1 knockout mice by recombinant Adeno-associated viral gene delivery of Homer1c. Neurobiol Learn Mem 2012; 97: 17-29.
17. Astary GW, Kantorovich S, Carney PR, Mareci TH, Sarntinoranont M. Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo. J Neurosci Methods 2010; 187: 129-137.
18. Nguyen JB, Sanchez-Pernaute R, Cunningham J, Bankiewicz KS. Convectionenhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 2001; 12: 1961-1964.
19. Mastakov MY, Baer K, Xu R, Fitzsimons H, During MJ. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol Ther 2001; 3: 225-232.
20. Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J et al. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol 2000; 164: 2-14.
21. Hadaczek P, Kohutnicka M, Krauze MT, Bringas J, Pivirotto P, Cunningham J et al. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum Gene Ther 2006; 17: 291-302.
22. Gerstein H, Lindstrom MJ, Burger C. Gene delivery of Homer1c rescues spatial learning in a rodent model of cognitive aging. Neurobiol Aging 2013; 34: 1963-1970.
23. Brown RH. A transgenic-mouse model of amyotrophic lateral sclerosis. N Engl J Med 1994; 331: 1091-1092.
24. Matalon R, Rady PL, Platt KA, Skinner HB, Quast MJ, Campbell GA et al. Knock-out mouse for Canavan disease: A model for gene transfer to the central nervous system. J Gene Med 2000; 2: 165-175.
25. Gerstein H, Hullinger R, Lindstrom MJ, Burger C. A behavioral paradigm to evaluate hippocampal performance in aged rodents for pharmacological and genetic target validation. PLoS One 2013; 8: E62360.
26. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature Methods 2012; 9: 671-675.
27. Burger C, Cecilia Lopez M, Feller JA, Baker HV, Muzyczka N, Mandel RJ. Changes in transcription within the CA1 field of the hippocampus are associated with age-related spatial learning impairments. Neurobiol Learn Mem 2007; 87: 21-41.